All Pharma News
Laurus Labs posts Q4 FY24 consolidated PAT at Rs. 75.61 Cr

Laurus Labs posts Q4 FY24 consolidated PAT at Rs. 75.61 Cr
INDINPHARMAPOST
25 Apr 2024
Share Share
Laurus Labs forms JV company

Laurus Labs forms JV company
INDINPHARMAPOST
16 Apr 2024
Share Share
Laurus` Generic Gabapentin Receives Approval in the U.S.

Laurus` Generic Gabapentin Receives Approval in the U.S.

FDA
08 Apr 2024
Share Share
Laurus Labs` Generic Bictegravir, Emtricitabine, Tenofovir Alafenamide Receives Approval in the U.S.

Laurus Labs` Generic Bictegravir, Emtricitabine, Tenofovir Alafenamide Receives Approval in the U.S.
FDA
02 Feb 2024
Share Share
Laurus Labs inks JV agreement with KRKA, Slovenia

Laurus Labs inks JV agreement with KRKA, Slovenia
INDIAN PHARMA POST
26 Jan 2024
Share Share
Laurus Labs posts Q3 FY24 consolidated PAT at Rs. 23.14 Cr

Laurus Labs posts Q3 FY24 consolidated PAT at Rs. 23.14 Cr
INDIAN PHARMA POST
25 Jan 2024
Share Share
FDA slams trio of Indian drugmakers with Form 483 filings

FDA slams trio of Indian drugmakers with Form 483 filings
Joseph Keenan FIERCE PHARMA
03 Jan 2024
Share Share
FDA Issues Form 483 to Laurus Synthesis Private Limited

FDA Issues Form 483 to Laurus Synthesis Private Limited
FDA
28 Dec 2023
Share Share
Laurus Labs acquires 87.59% stake in Laurus Bio Private

Laurus Labs acquires 87.59% stake in Laurus Bio Private
INDIAN PHARMA POST
25 Nov 2023
Share Share
Laurus Labs Q2 FY24 consolidated PAT up QOQ at Rs. 36.95 Cr

Laurus Labs Q2 FY24 consolidated PAT up QOQ at Rs. 36.95 Cr
INDIAN PHARMA POST
21 Oct 2023
Share Share